NCT04487587View on ClinicalTrials.gov

A Phase II Clinical Trial of Cediranib and Olaparib Maintenance in Advanced Recurrent Cervical Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

October 9, 2018

Primary Completion Date

March 1, 2025

Study Completion Date

March 1, 2026

Conditions
Cervical Cancer
Interventions
DRUG

Cediranib, Olaparib

Cediranib film coated tablet, Olaparib film coated tablet

Trial Locations (1)

CH63 4JY

Clatterbridge Cancer Centre, Metropolitan Borough of Wirral

All Listed Sponsors
collaborator

University of Liverpool

OTHER

lead

The Clatterbridge Cancer Centre NHS Foundation Trust

OTHER

NCT04487587 - A Phase II Clinical Trial of Cediranib and Olaparib Maintenance in Advanced Recurrent Cervical Cancer | Biotech Hunter | Biotech Hunter